Marc Le Bozec
Direktor/Vorstandsmitglied bei NH THERAGUIX SAS
Aktive Positionen von Marc Le Bozec
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NH THERAGUIX SAS | Direktor/Vorstandsmitglied | 22.02.2019 | - |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Direktor/Vorstandsmitglied | 24.05.2013 | - |
Vorsitzender | 24.05.2013 | - | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Direktor/Vorstandsmitglied | 12.06.2014 | - |
Treasurer | 12.06.2014 | - | |
Financière Arbevel SA
Financière Arbevel SA Investment ManagersFinance Financière Arbevel SA is an independent asset management firm headquartered in Paris, France. The firm was founded in 1997 and manages small and medium-sized French and European funds. Financière Arbevel is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI) which integrates environmental, social, and governance considerations into their investment process. | Portfolio Manager-Aktien | 01.12.2014 | - |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Clevexel Pharma SAS manufactures as well as distributes pharmaceutical products. It engages in biotechnological research. The company was founded by Christian Bloy, Xiuping Wang-Zhang and Laurent Benel in 2012 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - | - |
Transcure Bioservices SAS
Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès. | Direktor/Vorstandsmitglied | - | - |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | - | - |
░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░ ░░░░░░░░░░░ ░░ ░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
Karriereverlauf von Marc Le Bozec
Ehemalige bekannte Positionen von Marc Le Bozec
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Marc Le Bozec
École des Hautes Études Commerciales de Paris | Undergraduate Degree |
Statistik
International
Frankreich | 16 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 11 |
Chairman | 3 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 9 |
Commercial Services | 5 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CELLECTIS S.A. | Health Technology |
Private Unternehmen | 14 |
---|---|
Financière Arbevel SA
Financière Arbevel SA Investment ManagersFinance Financière Arbevel SA is an independent asset management firm headquartered in Paris, France. The firm was founded in 1997 and manages small and medium-sized French and European funds. Financière Arbevel is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI) which integrates environmental, social, and governance considerations into their investment process. | Finance |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology BioProtein Technologies SA develops recombinant therapeutic proteins and vaccines. Its proprietary technology offers customized packages supplying highly purified biopharmaceuticals. The firm provides pharmaceutical and biotechnology companies with integrated services from gene expression to industrial production of proteins and vaccines in milk. The company was founded on July 1, 1988 by Marc Le Bozec, Louis-Marie Houdebine, Jean-Paul Renard, Bernard Jégou and François Deneux and is headquartered in Jouy-en-Josas, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Health Technology |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Clevexel Pharma SAS manufactures as well as distributes pharmaceutical products. It engages in biotechnological research. The company was founded by Christian Bloy, Xiuping Wang-Zhang and Laurent Benel in 2012 and is headquartered in Paris, France. | Health Technology |
Transcure Bioservices SAS
Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France. | Commercial Services |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France. | Health Technology |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France. | Commercial Services |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès. | Health Technology |
NH TherAguix SAS
NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation. | Health Technology |
Monatomics Technology SAS | |
La Financière du Faouet SASU |
- Börse
- Insiders
- Marc Le Bozec
- Erfahrung